Abstract: The present invention relates to pharmaceutical compositions comprising a fibrate (e.g. ciprofibrate, gemfibrozil, benzafibrate, and fenofibrate) and a polychitosamine (e.g. chitosan) having molecular weights of less than 650 Kda and degrees of deacetylation of from 70% to 100%. Uses of said compositions for the treatment of hyperlipidemia and associated conditions (e.g. hypercholesterolemia, atherosclerosis, coronary heart disease and cardiovascular disease) or as functional foods are also disclosed.
Type:
Application
Filed:
September 28, 2006
Publication date:
November 27, 2008
Applicant:
DNP Canada, Inc.
Inventors:
Andre Aube, Ryszard Brzezinski, Gilles Dupuis, Jean-Guy Lehoux